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The effect of ventilation tube insertion on 
quality of life in children with persistent 
otitis media with effusion 
 
Abstract 
 
Objectives 
To determine the effect of ventilation tube (VT) surgery on quality of life (QoL) in children with persistent otitis 
media with effusion (OME). 
 
Design 
Secondary analysis of trial data (oral steroids versus placebo for persistent OME), comparing QoL by history 
of VT surgery performed between 5 weeks and 12 months post randomisation. Multilevel regression models 
were used to identify the association between VT surgery and QoL scores at 12 months, controlling for pre-
exposure risk factors associated with surgery, including pre-surgery hearing level. 
 
Setting 
Ear, nose and throat (ENT), paediatric audiology and audiovestibular medicine (AVM) departments in Wales 
and England. 
  
Participants 
327 children aged 2 to 8 years old with OME symptoms for at least three months and audiometry proven bi-
lateral hearing loss with VT surgery status. 
 
Main outcome measures 
Otitis Media questionnaire (OM8-30) and Paediatric Quality of Life Inventory (PedsQL) total and subscale 
scores, and the Health Utilities Index Mark 3 (HUI3) at 12 months post randomisation.  
 
Results 
Participants who had VT surgery had no significant difference in OM8-30, PedsQL or HUI total scores. OM8-
30 hearing difficulty (HD) subscale scores at 12 months were better in those who had VT surgery (adjusted 
mean difference (aMD)=-0.46 (95% confidence interval -0.69 to -0.23), p<0.001), and this varied by when the 
surgery occurred (aMD for surgery between 5 weeks and 6 months = -0.4 (-0.67 to -0.13), p=0.004 and be-
tween 6 and 12 months =-0.54, (-0.87 to-0.22),p=0.001)). 
 
Conclusion  
VT surgery was associated with an improvement in HD related functional health status but no change in 
overall QoL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Otitis media with effusion (OME) is a common condition in children, defined as fluid accumulation within the 
middle ear space. By the age of four years, 80% of children will have had an episode of OME, but the majority 
resolve spontaneously within three months [1-6]. Despite the high probability of resolution, 5% of preschool 
children under the age of 5 years will develop bilateral, persistent disease leading to hearing loss [5, 6] with a 
potentially detrimental effect on early development in terms of language and social development, behaviour, 
IQ and reading [1-4, 6]. Evidence-based management options for persistent OME, after a 3 month period of 
‘watchful waiting’, are hearing aids or the surgical insertion of ventilation tubes (VT) [5, 7]. VT surgery has been 
the mainstay of treatment for persistent OME. However, the number of operations in England has declined 
principally due to the introduction of the ‘watchful waiting’ approach which allows longer for spontaneous res-
olution [2, 5-7]. Despite this, VT insertion remains the most common operation performed within the UK. How-
ever, there is considerable variation both between countries and within the UK, unlikely to be representative 
of regional population variations [2, 5, 8].  
 
VT surgery has been shown to have a modest effect on hearing in the first 6 months, with an improvement of 
between 4-10dB, however this improvement decreases with time resulting in no benefit at 12 months [6, 8]. 
Despite this, studies demonstrating a positive impact on quality of life (QoL) have been limited [8-12]. Sev-
eral uncontrolled before and after studies have shown an improvement in QoL following surgery, with a num-
ber including a mixed cohort of children with both recurrent acute otitis media and OME [13-17]. We there-
fore set out to assess the effect of VT insertion on functional health status and quality of life in a secondary 
analysis of the 12-month follow-up of a randomised controlled trial of oral steroids for OME in children with 
persistent OME. A secondary objective was to identify factors associated with undergoing VT surgery. This 
may be helpful in targeting potential overuse of this surgical procedure. 
 
Materials and methods 
This was a secondary analysis of data from the Oral STteroids for the Resolution of OME In CHildren 
(OSTRICH) trial, a double-blind randomised controlled trial of the effect of a one-week course oral steroids 
on hearing at five weeks [18]. Trial participants were aged 2 to 8 years old with at least three months of hear-
ing loss secondary to bilateral OME and were recruited from ear, nose and throat (ENT) outpatients or paedi-
atric audiology and audiovestibular medicine (AVM) departments across Wales and England. For further de-
tails of the OSTRICH trial study design, see the published study protocol [5].  
 
A total of 380 children were included in the OSTRICH trial. Baseline demographics and medical history were 
collected from eligible participants including audiology, tympanometry and otoscopy assessments. These were 
repeated at 5 weeks, 6 and 12 months post-randomisation. In current practice, the recommended standard 
methods to assess hearing thresholds are ear-specific pure-tone audiometry (PTA) at 0.5, 1, 2 and 4 kHz in 
children aged three years or older and soundfield VRA in children aged less than three years. However, 
equally, those over three years of age may not comply with PTA. Therefore, it was recommended that the 
audiologist or clinician use their judgement on the most appropriate method of assessment for the child and, 
when possible, maintain that method for the subsequent follow-ups.  
 
The child’s parent or guardian was asked to complete the Otitis Media questionnaire (OM8-30), the Paediatric 
Quality of Life Inventory (PedsQL) and Health Utilities Index Mark 3 (HUI3) quality of life assessment tools at 
baseline and at 5 weeks, 6 and 12 months. The OM8-30 questionnaire is a specific functional health assess-
ment tool that assesses the impact of chronic otitis media on three facets of development: physical develop-
mental, general development and hearing difficulties [19]. Better functional health is indicated by a negative or 
low score. The HUI3 is multi attribute measure of health status, where a higher score indicates a better quality 
of life, with a maximum score of 1.00 [20]. The mean score of the eight attributes was used during this study. 
The PedsQL is a generic paediatric health-related quality of life assessment tool, based on five domains con-
sisting of physical health, emotional functioning, social functioning, school functioning, and psychosocial func-
tioning. These can be combined to create an overall score. A higher score indicates a better QoL, with a 
maximum score of 100 [21]. For the purposes of this study we will refer to these instruments collectively as 
measuring ‘quality of life’. The outcomes of this study will be the aforementioned quality of life measures, 
collected at 12 months follow-up.    
 
Exposure 
Participating children were asked not to undergo VT surgery within the first five weeks of follow-up (from ran-
domisation). Thereafter, decisions about surgery or other re-interventions were made according to usual care 
processes. At six- and 12-months follow-up parents were asked whether their child had undergone VT surgery. 
 
 
Children who had missing responses at both time-points or one of the time points and had not had ventilation 
tube surgery at the other were classified as having missing VT surgery data.  
 
Statistical Analysis  
Exposure (VT surgery or not) was characterised using baseline and five-week follow-up data with the time-
point closest to the exposure period used (i.e. where risk factors are measured at both time points, the five-
weeks data has been used in the model). These factors were described using appropriate summary statistics 
(mean alongside standard deviation, median alongside inter quartile range, n (%)). To identify risk factors 
associated with undergoing VT surgery 5 weeks post randomisation (and subsequently adjust for them in the 
QoL at 12-month models) we used multilevel logistic regression models controlling for clustering of outcomes 
by recruitment site. After examining associations between factors and VT surgery at a univariable level, can-
didate predictors were identified using a 10% significance cut off to take forward to identify factors inde-
pendently predictive of VT surgery in a multivariable model. Estimates are presented as odds ratios (ORs) 
alongside 95% and p-values.  
 
To examine the associations between VT surgery and the quality of life outcomes at 12 months follow-up, 
multilevel regression models that controlled for factors associated with having VT surgery, including pre-sur-
gery hearing threshold, were used. For the OM8-30 assessment tool at 12 months, a linear regression model 
was used, and estimates reported as mean differences. HUI3 outcomes was examined as a binary variable 
(score=1-perfect health, <1 non-perfect health) due to skewedness and estimates presented as odds ratios 
(ORs). PedsQL at 12 months was compared between the VT and non-surgical groups using a hurdle regres-
sion model used to reflect the skewedness and upper bounded (ceiling) nature of the scores. Two estimates 
are reported for the hurdle model; first a log-odds (perfect quality of life score=100 or non-perfect score<100) 
and second a mean difference in QoL between groups in those with a non-perfect score (<100). The impact 
of timing of surgery was also analysed where QoL, using the three assessment tools, was compared between 
participants having no surgery, surgery between 5 weeks and 6 months post recruitment, versus patients 
undergoing surgery between 6- and 12-months post recruitment. Two participants were removed at this stage 
as the timing of their VT surgery was unclear. All estimates here are presented unadjusted and adjusted (for 
the risk factors associated with VT surgery) and reported alongside 95% confidence intervals (95% CI) and p-
values.  
 
Univariable Cox regression models were performed to identify variables associated with time to VT surgery. 
The variables that were significantly associated at the 10% level were then analysed using a multivariable Cox 
regression model. Estimates from this analysis are presented as hazard ratios (HRs) with 95% CIs and p-
values.  
 
Stata version 16 [22] and SPSS version 23 [23] were used for statistical analysis. 
 
Ethical Considerations 
Ethical approval for the OSTRICH trial [18] was obtained from an NHS research ethics committee, recog-
nised by the UK Ethics Committee Authority (UKECA), the National Research Ethics Service Research Eth-
ics Committee for Wales on Feb 28, 2013 (reference number 13/WA/0004). The trial protocol was reviewed 
and approved by the Wales Research Ethics Committee 3, recognised by the UKECA. All hospital sites re-
ceived research and development approval from the respective NHS Health Boards and Trusts in England 
and Wales. Clinical trial authorisation was obtained from the Medicines and Healthcare products Regulatory 
Agency (MHRA). The trial was overseen by independent trial steering and data monitoring committees.  
Results 
Of the 380 participants recruited to the OSTRICH trial, 327 had complete data on VT surgery status over the 
12-month follow up period and therefore were included in this study (see figure 1). Of these, 123 (38%) had 
VT surgery during the course of the study. Fifty-three participants did not have data on VT surgery and were 
therefore excluded from the analysis. Comparing these patients to those included in the study demonstrated 
that household smoking was more common (51% vs 25% respectively, p<0.001), as was a history of eczema 
(32% vs 20% respectively, p=0.045), although overall atopy rate was comparable. The other baseline charac-
teristics were comparable, including socioeconomic status.  
 
Risk factors for VT surgery 
After adjustment for recruitment site, children who underwent VT surgery were more likely to report being of 
Asian ethnicity (and less likely to report being white) than those who did not undergo VT surgery, and were 
 
 
more likely to have had OME for a longer duration (Table 1). They were also more likely to have worse hearing 
levels at 5 weeks post-randomisation, and worse quality of life outcomes (specifically in the overall OM8-30 
score, the OM8-30 physical health and reported hearing difficulties facets, and the PedsQL psychosocial and 
social functioning domains). When entered into the multivariable model, only hearing level remained inde-
pendently associated with VT surgery. 
 
 No VT sur-
gery (n=204) 
VT surgery 
(n=123) 
Unadjusted* OR† (95% CI), 
p-value 
Adjusted** OR† (95% 
CI), p-value 
Characteristics at recruitment     
Age (years) Mean (SD) 5.15 (1.62) 5.15 (1.54) 0.96 (0.80 to 1.14), 0.62 - 
Gender      
Female 93 (45.6) 53 (43.1) Reference group  
Male 111 (54.4) 70 (56.9) 1.00 (0.58 to 1.70), 0.99 - 
Ethnicity   Overall p-value=0.022 Overall p-value=0.059 
White 169 (88.9) 84 (73.0) Reference group Reference group 
Mixed/multiple 7 (3.7) 10 (8.7) 2.89 (0.91 to 9.15), 0.072 2.66 (0.69 to 10.30), 0.16 
Asian/Asian British 9 (4.7) 19 (16.5) 4.03 (1.49 to 10.88), 0.006 4.02 (1.31 to 12.31), 
0.015 
Black/African/Carib-
bean/Black British 3 (1.6) 2 (1.7) 1.36 (0.18 to 10.61), 0.77 2.20 (0.22 to 22.06), 0.50 
Other 2 (1.1) 0 (0.0) - - 
Missing data 14 8   
Socioeconomic status    Overall p-value=0.78 - 
1 - least deprived 31 (15.2) 22 (17.9) Reference group   
2 18 (8.8) 15 (12.2) 0.99 (0.35 to 2.82), 0.98  
3 60 (29.4) 22 (17.9) 0.65 (0.28 to 1.54), 0.33  
4 44 (21.6) 35 (28.5) 1.05 (0.45 to 2.46), 0.91  
5 - most deprived 51 (25.0) 29 (23.6) 0.87 (0.35 to 2.14), 0.76  
Season recruited    Overall p-value=0.15  
Spring  
(March to May) 61 (29.9) 50 (40.7) Reference group 
 
Summer  
(June to August) 41 (20.1) 15 (12.2) 0.40 (0.18 to 0.91), 0.028 
 
Autumn  
(September to Novem-
ber) 
35 (17.2) 21 (17.1) 0.90 (0.42 to 1.94), 0.79 
 
Winter  
(December to February) 67 (32.8) 37 (30.1) 0.67 (0.35 to 1.29), 0.23 
 
First episode of OME?     
 
 
 No VT sur-
gery (n=204) 
VT surgery 
(n=123) 
Unadjusted* OR† (95% CI), 
p-value 
Adjusted** OR† (95% 
CI), p-value 
No 58 (28.4) 43 (35.0) Reference group   
Yes 146 (71.6) 80 (65.0) 1.01 (0.56 to 1.81), 0.98  
Duration of current episode of 
OME* 
  Overall p-value=0.009 Overall p-value=0.091 
<6 months 29 (14.2) 9 (7.3) Reference group  Reference group 
6 to <9 months 25 (12.3) 20 (16.3) 2.69 (0.88 to 8.21), 0.082 2.78 (0.68 to 11.34), 0.16 
9 to <12 months 15 (7.4) 18 (14.6) 7.86 (2.30 to 26.9), 0.001 7.00 (1.54 to 31.76), 
0.012 
≥12 months 135 (66.2) 76 (61.8) 3.91 (1.49 to 10.3), 0.006 3.37 (0.97 to 11.69), 
0.056 
Relatives with glue ear   Overall p-value=0.64  
No 114 (55.9) 74 (60.2) Reference group  
Yes 49 (24.0) 19 (15.4) 0.72 (0.36 to 1.44), 0.36  
N/A - no siblings 41 (20.1) 28 (22.8) 1.09 (0.56 to 2.13), 0.80  
Missing data 0 2 -  
Household smoking N (%) Yes*** 50 (24.5) 30 (24.4) 1.29 (0.69 to 2.42), 0.42  
Atopy N (%) Yes 69 (33.8) 35 (28.5) 0.86 (0.49 to 1.54), 0.62  
Previous Adeno-tonsillectomy N 
(%) Yes 10 (4.9) 9 (7.3) 1.54 (0.52 to 4.56), 0.43 
 
Previous grommet surgery N (%) 
Yes 12 (5.9) 17 (13.8) 1.88 (0.76 to 4.65), 0.17 
 
Use of hearing aids N (%) Yes 37 (18.1) 11 (8.9) 0.725 (0.31 to 1.69), 0.46   
Trial arm     
Placebo 98 (48.0) 61 (49.6) Reference group  
Steroids 106 (52.0) 62 (50.4) 0.99 (0.59 to 1.66), 0.97  
5-week follow-up characteristics     
Average decibel (dBHL) that is au-
dible, Mean (SD) of the average of 
the two ears 
28.3 (11.2) 31.4 (9.2) 1.04 (1.01 to 1.07), 0.003 1.03 (1.01 to 1.06), 0.044 
Tympanogram     
No type B ears 3 (1.5) 1(0.8) Reference group   
At least one Type B ear 7 (3.4) 8 (6.5) 0.43 (0.11 to 1.65), 0.22  
Missing data 0 1 -  
 
 
 No VT sur-
gery (n=204) 
VT surgery 
(n=123) 
Unadjusted* OR† (95% CI), 
p-value 
Adjusted** OR† (95% 
CI), p-value 
Quality of Life measures     
OM8-30 Mean (SD)     
Infection related physi-
cal health 
-0.39 (0.97) -0.28 (1.04) 1.28 (0.98 to 1.68), 0.075 1.10 (0.72 to 1.67), 0.66 
General development 0.50 (1.20) 0.55 (1.21) 1.13 (0.90 to 1.42), 0.28  
Reported hearing diffi-
culties 
0.55 (0.90) 0.76 (0.79) 1.67 (1.19 to 2.33), 0.003 1.48 (0.93 to 2.35), 0.098 
Overall 0.32 (1.09) 0.52 (1.12) 1.44 (1.12 to 1.85), 0.005 1.08 (0.64 to 1.83), 0.76 
Missing 1 0   
HUI3 binary N (%)     
Non perfect health (<1) 142 (78.0) 82 (78.9) Reference group  
Perfect health (=1) 40 (22.0) 22 (21.2) 0.68 (0.34 to 1.37), 0.28  
Missing 22 19   
PedsQL Mean (SD)     
Physical health 86.25 (17.4) 82.93 (21.6) 0.99 (0.98 to 1.01), 0.27  
Emotional functioning 74.36 (20.3) 69.61 (23.0) 0.99 (0.98 to 1.00), 0.17  
Psychosocial health 78.87 (16.9) 75.42 (19.7) 0.99 (0.97 to 1.00), 0.086 1.00 (0.96 to 1.04), 0.92 
Social functioning 85.56 (19.6) 82.44 (22.7) 0.99 (0.98 to 1.00), 0.096 0.99 (0.97 to 1.02), 0.72 
School functioning 76.60 (19.1) 75.74 (18.6) 0.99 (0.98 to 1.01), 0.27  
Total score 81.57 (15.6) 78.49 (18.1) 0.99 (0.97 to 1.00), 0.14  
 
 
 
Table 1. Pre-exposure sociodemographics and characteristics in each exposure group (VT surgery) 
* adjusted for site; ** adjusted for site and all other risk factors in multivariable model; *** household smoking of approximately 5 hours 
per week or more, † OR predicting VT surgery. 
OM8-30: a negative or low score indicates a better quality of life (11). 
Health Utilities Index mark 3 (HUI3): a higher score indicates a better quality of life, with a maximum score of 1.00(12). 
PedsQL: a higher score indicates a better QoL, with a maximum score of 100(13). 
VT - Ventilation tube, SD - standard deviation, IQR - interquartile range. P values in bold statistically significant. 
 
 
Association between VT surgery and Quality of Life at 12 months  
For almost all outcomes the point estimates for quality of life at 12 months follow-up suggested better QoL 
for participants who underwent VT surgery between 5 weeks and 12 months follow-up compared to those 
who did not, but the difference was only statistically significant for the OM8-30 reported hearing difficulties 
facet (Table 2). This association remained after adjusting for factors significantly associated with VT surgery 
and recruitment site. There was no significant difference in the other OM8-30 facets, HUI3 score, or any of 
the five domains of the PedsQL.  
 
 
 
 
 
 
 No VT surgery 
(n= 204) 
VT surgery 
(n=123) 
Unadjusted* difference in 
means (95% CI), p-value 
Adjusted** difference in 
means, p-value 
OM8-30 Mean (SD)     
Infection related physical health -0.69 (0.94) -0.52 (1.04) 0.19 (-0.05 to 0.43), 0.11  
General development 0.30 (1.21) 0.26 (1.10) -0.004 (-0.29 to 0.29), 0.98  
Reported hearing difficulties 0.08 (0.93) -0.25 (0.97) -0.27 (-0.50 to -0.03), 
0.026 
-0.46 (-0.69 to -0.23), 
<0.001 
Overall -0.22 (1.22) -0.29 (1.13) 0.03 (-0.26 to 0.33), 0.82  
       Missing 12 21   
HUI3 binary N (%)   Unadjusted* Odds ratio 
(95% CI), p-value 
 
Non perfect health (score<1) 127 (69.8) 63 (63.0)  Reference  
Perfect health (score=1) 55 (30.2) 37 (37.0)  1.24 (0.70 to 2.22), 0.46  
Missing 22 23   
PedsQL median (IQR)   Unadjusted* mean differ-
ence/log-odds ratio (95% 
CI), p-value 
 
Physical health 93.8 (84.4 to 
100.0) 
93.8 (86.6 to 
100.0) 
28.38 (-15.49 to 72.24), 
0.21 
-0.13 (-0.44 to 0.18), 0.41 
 
Emotional functioning 75.0 (60.0 to 
95.0) 
80.0 (60.0 to 
90.0) 
4.70 (-2.09 to 11.49), 0.18 
-0.27 (-0.62 to 0.08), 0.13 
 
Psychosocial health 82.7 (70.0 to 
93.2) 
82.7 (71.2 to 
92.0) 
5.25 (-3.42 to 13.92), 0.24 
-0.25 (-0.69 to 0.19), 0.26 
 
Total score 85.9 (75.0 to 
94.6) 
85.9 (78.3 to 
93.3) 
7.20 (-2.50 to 16.90), 0.15 
-0.33 (-0.79 to 0.13), 0.16 
 
Missing 12 22   
Social functioning 95.0 (75.0 to 
100.0) 
95.0 (80.0 to 
100.0) 
16.03 (-6.72 to 38.78), 0.17 
0.19 (-0.11 to 0.50), 0.21 
 
Missing 13 22   
School functioning 83.3 (65.0 to 
95.0)  
80.0 (61.9 to 
91.7) 
-1.91 (-9.14 to 5.32), 0.61 
-0.22 (-0.58 to 0.13), 0.22 
 
Missing 22 25   
 
 
 
 
 
 
Table 2. Results for Quality of life outcomes at 12 months by VT surgery status 
* adjusted for site; ** adjusted for site and ethnicity, duration of OME, and hearing and OM8-30 reported hearing difficulties at 5 weeks 
follow-up (pre-exposure). 
OM8-30: a negative or low score indicates a better quality of life (11). 
Health Utilities Index mark 3 (HUI3): a higher score indicates a better quality of life, with a maximum score of 1.00(12). 
PedsQL: a higher score indicates a better QoL, with a maximum score of 100(13). 
VT - Ventilation tube, SD - standard deviation, IQR - interquartile range. P values in bold statistically significant. 
 
 
 
Timing of VT surgery initially appeared to impact the degree of improvement in OM8-30 hearing related func-
tional health whereby children undergoing VT surgery 6 to 12 months after recruitment had the greatest im-
provement compared to the non-surgical group. However, after adjusting for hearing and OM8-30 hearing 
difficulties at 5 weeks, both children undergoing VT surgery earlier in the study at 5 weeks to 6 months (ad-
justed mean difference -0.40, (95% CI -0.67 to -0.13), p=0.004) and those who had surgery later, 6-12 
months (adjusted mean difference -0.54, (95% CI -0.87 to -0.22), p=0.001), had similar improvement in 
OM8-30 hearing related functional health compared to the non-surgical group (Table 3). Surgical timing did 
not appear to affect the other facets of OM8-30, or the PedsQL or HUI3 (Table 3). 
 
 
 
 
 
No VT surgery 
(n= 204) 
VT surgery 5 
weeks to 6 
months (n=87) 
VT surgery 6 to 12 
months (n=36) 
No surgery (ref) 
vs  
surgery 5 weeks 
to 6 months 
No surgery (ref) 
vs  
surgery 6 to 12 
months 
OM8-30 Mean 
(SD) 
   Adjusted* difference in means (95% 
CI), p-value 
Infection 
related 
physical 
health 
-0.69 (0.94) -0.63 (1.03) -0.28 (1.02) 0.06 (-0.25 to 
0.36), 0.71 
0.31 (-0.06 to 
0.69), 0.10 
General 
develop-
ment 
0.30 (1.21) 0.09 (1.12) 0.60 (0.97) -0.18 (-0.53 to 
0.16), 0.29 
0.26 (-0.16 to 
0.68), 0.22 
Reported 
hearing 
difficulties 
0.08 (0.93) -0.15 (1.01) -0.46 (0.84) -0.40 (-0.67 to -
0.13), 0.004 
-0.54 (-0.87 to -
0.22), 0.001 
Overall -0.22 (1.22) -0.42 (1.11) -0.02 (1.16) -0.27 (-0.61 to 
0.08), 0.13 
0.09 (-0.32 to 
0.51), 0.66 
       Missing 12 18 3   
HUI3 binary N (%)       
Non per-
fect health 
(score<1) 
127 (69.8) 44 (65.7) 19 (57.6) Adjusted* odds ratio (OR) (95% CI), 
p-value 
Perfect 
health 
(score=1) 
55 (30.2) 23 (34.3) 14 (42.4) 1.37 (0.61 to 3.08), 
0.45 
1.91 (0.78 to 
4.68), 0.16 
Missing 22 20 3   
PedsQL Median 
(IQR) 
   Adjusted* mean difference/log-odds 
ratio (95% CI), p-value 
Physical 
health 
93.75 (84.4 to 
100.0) 
93.75 (87.5 to 
100.0) 
92.19 (84.38 to 
96.88) 
13.50 (-12.19 to 
39.18), 0.30 
0.14 (-0.28 to 
0.56), 0.52 
13.62 (-15.40 to 
42.63), 0.36 
-0.34 (-0.90 to 
0.22), 0.24 
Emotional 
function-
ing 
75 (60 to 95) 80 (60 to 90) 70 (65 to 86.9) 6.50 (-2.03 to 
15.04), 0.14 
-0.10 (-0.58 to 
0.38), 0.68 
3.76 (-6.92 to 
14.45), 0.49 
-0.06 (-0.64 to 
0.53), 0.85 
Psychoso-
cial health 
82.69 (70.0 to 93.2) 84.62 (76.92 to 
93.33) 
79.55 (66.67 to 
86.25) 
  
Total 
score 
85.87 (75.0 to 
94.57) 
86.96 (80.48 to 
94.57) 
82.97 (75.0 to 
89.98) 
6.50 (-3.02 to 
15.97), 0.18 
0.31 (-0.31 to 
0.92), 0.32 
2.31 (-8.4 to 
13.1), 0.67  
-0.52 (-1.59 to 
0.54), 0.34 
Missing 12 18 4   
 
 
 
 
 
 
Table 3. Quality of life at 12 months post recruitment by timing of surgery.  
* adjusted for site and ethnicity, duration of OME, and hearing and OM8-30 reported hearing difficulties at 5 weeks follow-up (pre-expo-
sure). 
OM8-30: a negative or low score indicates a better quality of life[19]. 
Health Utilities Index mark 3: a higher score indicates a better quality of life, with a maximum score of 1.00[20].  
PedsQL: a higher score indicates a better QoL, with a maximum score of 100[21]. 
SD - standard deviation, IQR - interquartile range. P values in bold statistically significant. 
 
 
Social 
function-
ing 
95 (750 to 100) 100 (90 to 100) 90 (71.25 to 100) 16.92 (-7.07 to 
40.91), 0.17 
0.43 (0.02 to 0.84), 
0.04 
11.14 (-12.54 to 
34.82), 0.36 
-0.15 (-0.67 to 
0.37), 0.58 
Missing 13 18 4   
School 
function-
ing 
83.33 (65.0 to 95.0) 83.33 (62.5 to 
91.67) 
70 (60 to 85) 0.88 (-8.19 to 
9.95), 0.85 
0.04 (-0.44 to 
0.53), 0.86 
-3.16 (-13.54 to 
7.21), 0.55 
-0.70 (-1.47 to 
0.07), 0.08 
Missing 22 20 5   
 
 
Time to VT Surgery 
Multivariable Cox regression analysis, after adjusting for recruitment site, revealed that Asian ethnicity and 
mixed ethnicity were independently associated with a shorter time to VT surgery. 
 
 Adjusted* HR 95% CI P value 
Ethnicity    
White reference   
Mixed/multiple 2.06 1.03 to 4.14 0.042 
Asian/Asian British 2.21 1.23 to 3.97 0.008 
Black/African/Caribbean/ Black British 0.81 0.18 to 3.76 0.79 
Other Too few numbers for analysis 
Previous grommet surgery 
1.64 0.92 to 2.94 0.096 
Hearing aids 0.81 0.41 to 1.61 0.55 
Average hearing loss (both ears, using all methods of assess-
ment) 
1.14 0.82 to 1.58 0.45 
 
 
Table 4. Cox regression multivariable model  
* adjusted for site and other variables in model. HR – hazard ratio.  
 
Discussion 
In this secondary analysis of data from a trial of oral steroids for children with persistent OME, we found no 
evidence of a significant association between having VT surgery and an improvement in overall health-related 
quality of life at 12 months post-recruitment, when measured using total OM8-30, PedsQL or HUI3 scores. 
However, having VT surgery was associated with better OM8-30 ‘hearing difficulties’ facet scores at 12 
months, even after adjusting for pre-exposure hearing level. Further analysis revealed that this was a signifi-
cant association for both those who had undergone their VT surgery earlier in the study (5 weeks to 6 months 
post requirement) and those who underwent surgery later (6-12 months post recruitment) compared to children 
not undergoing surgery. We also found that hearing level post randomisation was independently associated 
with an increased odds of having VT surgery and that being of Asian or mixed/multiple ethnicities was associ-
ated with a shorter time to surgery.  
 
Our finding that hearing level pre-exposure was independently associated with an increased odds of VT sur-
gery is not surprising. Children with more profound hearing loss are more likely to have surgery recommend 
by their responsible clinician, and parents are more likely to accept this recommendation. Interestingly, other 
baseline factors likely to be related to disease severity such as duration of OME, previous history of OME or 
VT surgery and QoL measures were not independently associated with having surgery. One possible expla-
nation for the lack of association between hearing related functional health at baseline and VT surgery is the 
poor correlation that has been demonstrated between objective and subjective (parent reported) hearing loss 
[15]. It has been suggested that parents often under-estimate the degree of hearing loss their child is experi-
encing and overestimate their health related QoL and may explain the lack of association we have also found 
in this regard [15].   
 
Results of studies analysing the QoL effects post VT surgery, compared to a non-surgical group, have been 
mixed with the majority demonstrating no overall QoL benefit in OME and therefore similar to our results in 
 
 
terms of overall QoL [8-10, 24]. However, we did demonstrate an improvement in functional health related to 
hearing difficulties in those who underwent VT surgery compared to those that did not. This improvement in 
function health remained even after adjusting for pre-exposure hearing level, which was associated with an 
increased odds of surgery. This result has not been demonstrated previously as previous studies in this area 
have been observational before and after studies that have not made a comparison with a non-surgical popu-
lation. Our results therefore add further evidence to suggest VT surgery improves hearing related QoL, at least 
within the first 12 months post-surgery. 
 
As far as we are aware, this is the first study to demonstrate a shorter time to VT surgery in children with Asian 
and mixed ethnicity. This association was maintained after controlling for recruitment site and measured base-
line characteristics such as socioeconomic status and family history. Cultural and behavioural factors are the 
most likely explanations for this association, but it warrants further study. 
 
The major strengths of this study are the breadth of outcome measures and potential confounders measured 
in the OSTRICH study. To our knowledge, this is the first study to assess the impact of VT on functional 
health status using the OME disease specific assessment tool OM8-30. We found no association between 
having VT surgery and any of the three outcome measures used in this study but did find a difference in one 
of the facet scores of one of the instruments. This was an exploratory analysis and it is possible that it is a 
type I error. However, our finding is certainly consistent with previously published data on VT surgery and 
hearing loss. A further limitation of this study is that most of the QoL and functional health status data were 
collected via parent-reported questionnaires, and as parents were aware of whether their child had had VT 
surgery there is a risk of response bias. However, we used validated instruments which is likely to have mini-
mised any bias, and it has previously been shown that parent-reported QoL scores are generally congruent 
with child self-rated QoL with regard to physical functioning or physical symptoms [25]. A final limitation is 
that as an exploratory observational study, the pre exposure groups were not entirely comparable, in particu-
lar hearing thresholds were higher in the group that had VT surgery. However, this was adjusted for within 
the multilevel regression models, therefore minimising the impact of this potential confounding factor. 
 
In conclusion, to our knowledge this is the first study of the impact of VT surgery on QoL that compares a 
surgical and non-surgical patient population using an OME disease specific QoL tool. This study found no 
evidence of a beneficial effect of VT surgery on overall QoL but did find evidence of a beneficial effect on 
hearing difficulty related health status. We also identified that Asian and mixed ethnicity appears to reduce 
time to surgery, a finding that has not been previously shown.  
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Figure 1. Flow chart demonstrating patient numbers and patient drop out numbers at the 
various study stages. 
 
